Results 21 to 30 of about 515,775 (310)

Influenza

open access: yesThe Lancet, 2022
Annual seasonal influenza epidemics of variable severity caused by influenza A and B virus infections result in substantial disease burden worldwide. Seasonal influenza virus circulation declined markedly in 2020-21 after SARS-CoV-2 emerged but increased in 2021-22.
Uyeki, Timothy M   +4 more
openaire   +2 more sources

GENETIC AND ANTIGENIC CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS STRAINS ISOLATED IN ST. PETERSBURG IN 2013-2016

open access: yesВопросы вирусологии, 2017
Antigenic and genetic characteristics of Russian RSV isolates are presented for the first time. Of the 69 strains isolated in St. Petersburg, 93% belonged to the RSV-A antigenic group.
V. Z. Krivitskaya   +12 more
doaj   +1 more source

Influenza [PDF]

open access: yesThe Indian Journal of Pediatrics, 2020
Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods.
openaire   +2 more sources

Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg

open access: yesЭпидемиология и вакцинопрофилактика, 2020
Background. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health.
M. K. Erofeeva   +8 more
doaj   +1 more source

SAFETY AND IMMUNOGENICITY OF COLD-ADAPTED RECOMBINANT INFLUENZA VECTOR EXPRESSING ESAT-6 AND AG85А ANTIGENS OF M. TUBERCULOSIS

open access: yesВопросы вирусологии, 2017
Recombinant viral vectors represent one of the most promising platforms for creating a new generation of vaccines against tuberculosis. We constructed a vaccine candidate based on a cold-adapted influenza vector with a truncated NS1 protein containing an
M. V. Sergeeva   +8 more
doaj   +1 more source

CROSS-PROTECTIVE PROPERTIES OF AN INFLUENZA VACCINE BASED ON HBC4M2E RECOMBINANT PROTEIN

open access: yesВопросы вирусологии, 2018
One of the main problems in the area of influenza prophylaxis and pandemic prevention is the development of cross-reactive vaccines, i.e. vaccines directed against all subtypes of human influenza viruses.
L. M. Tsybalova   +8 more
doaj   +1 more source

Features 2016–2018 current human influenza A(H3N2) viruses circulating in Russia

open access: yesИнфекция и иммунитет, 2020
Influenza A(H3N2) viruses demonstrate the highest level of evolutionary variability compared to other influenza viruses circulating in human population.
P. A. Petrova   +7 more
doaj   +1 more source

Avian influenza [PDF]

open access: yesEFSA Journal, 2017
Previous introductions of highly pathogenic avian influenza virus (HPAIV) to the EU were most likely via migratory wild birds. A mathematical model has been developed which indicated that virus amplification and spread may take place when wild bird populations of sufficient size within EU become infected.
Health, EFSA Panel on Animal   +35 more
openaire   +7 more sources

Study of the medicine MestaMidin®-nos virucidal activity of against influenza and ARD pathogens

open access: yesМедицинский совет, 2021
Introduction. Respiratory diseases have always been a serious threat to public health, but in 2020 the situation deteriorated significantly due to the rapid development of the coronavirus infection COVID-19.
A. A. Shtro   +5 more
doaj   +1 more source

Features of Epidemic Process of Influenza and its Etiology in the Countries of the Northern and Southern Hemispheres in the Period of Circulation of Pandemic Virus A(H1N1)pdm09 (According to WHO)

open access: yesЭпидемиология и вакцинопрофилактика, 2020
Relevance. Influenza is characterized by global distribution and the difference in its seasonality in countries with temperate and tropical climates. The importance of studying antigenic variation of influenza viruses due to the fact that changes in the ...
L. S. Karpova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy